Canine ehrlichiosis vaccine developed in Israel

01/2/2013 | Israel21c

Veterinary researchers in Israel have developed the first vaccine for canine monocytic ehrlichiosis, a potentially deadly tick-borne disease that affects dogs. Although more research is needed to ensure that the vaccine protects against other strains, a commercial vaccine will likely be developed.

View Full Article in:

Israel21c

Published in Brief:

SmartBrief Job Listings for Retail

Job Title Company Location
Commercial Building Products Sales Specialist
Parksite Inc
Columbia, SC
Human Resources Business Partner
Brooks Brothers
New York, New York
Store Manager
The Container Store
DALLAS, Texas
General Manager
Goodwill Industries of Southern New Jersey and Philadelphia
Aberdeen, New Jersey
Director of Business Continuity
J.Crew
New York, New York